Sildenafil and tadalafil
may place survivors of myocardial infarction at risk for visual loss
due to non-arteritic anterior ischemic optic neuropathy
Survivors of myocardial infarction who take
either sildenafil or tadalafil for erectile dysfunction may have
increased risk for visual loss from non-arteritic anterior ischemic
optic neuropathy (NAION), according to an article in the February
issue of the British Journal of Ophthalmology.
"We found a strong link between use of Viagra or Cialis and
NAION in men with a history of heart attack," said Gerald McGwin,
PhD, lead author of the study. "We found similar results in
men with hypertension that, while not as dramatic, are substantial
enough to indicate that men with a history of heart disease should
be warned of the risks of NAION before use of these medications."
The retrospective matched case-control study involved 38 US men
diagnosed with the neuropathy at one academic ophthalmology practice
and 38 controls without the optic disease. Medication history, including
use of either sildenafil or tadalafil, was obtained via interview.
Overall, men with the neuropathy were not more likely to report
use of either drug than their age-matched controls. However, there
was a statistically significant correlation between drug use and
neuropathy among men with a history of myocardial infarction. A
correlation that did not reach statistical significance was found
among men with hypertension.
|